Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 169 entries
Sorted by: Best Match Show Resources per page
Highlighting the medical applications of 3D printing in Egypt.

Annals of translational medicine

Hafez MA, Abdelghany K, Hamza H.
PMID: 26807414
Ann Transl Med. 2015 Dec;3(22):359. doi: 10.3978/j.issn.2305-5839.2015.12.01.

Computer-assisted designing/computer-assisted manufacturing (CAD/CAM) technology has enabled medical practitioners to tailor physical models in a patient and purpose-specific fashion. It allows the designing and manufacturing of templates, appliances and devices with a high range of accuracy using biocompatible materials....

Cite
Hafez MA, Abdelghany K, Hamza H. Highlighting the medical applications of 3D printing in Egypt. Ann Transl Med. 2015;3(22):359doi: 10.3978/j.issn.2305-5839.2015.12.01.
Hafez, M. A., Abdelghany, K., & Hamza, H. (2015). Highlighting the medical applications of 3D printing in Egypt. Annals of translational medicine, 3(22), 359. https://doi.org/10.3978/j.issn.2305-5839.2015.12.01
Hafez, Mahmoud A, et al. "Highlighting the medical applications of 3D printing in Egypt." Annals of translational medicine vol. 3,22 (2015): 359. doi: https://doi.org/10.3978/j.issn.2305-5839.2015.12.01
Hafez MA, Abdelghany K, Hamza H. Highlighting the medical applications of 3D printing in Egypt. Ann Transl Med. 2015 Dec;3(22):359. doi: 10.3978/j.issn.2305-5839.2015.12.01. PMID: 26807414; PMCID: PMC4701521.
Copy Download .nbib Format: NLM
MHDA-Functionalized Multiwall Carbon Nanotubes for detecting non-aromatic VOCs.

Scientific reports

Thamri A, Baccar H, Struzzi C, Bittencourt C, Abdelghani A, Llobet E.
PMID: 27721503
Sci Rep. 2016 Oct 10;6:35130. doi: 10.1038/srep35130.

The chemical modification of multiwalled carbon nanotubes (MWCNTs) with a long chain mercapto acid is reported as a way to improve sensitivity and response time of gas sensors for detecting alcohols, acetone and toxic gases such as DMMP. We...

Cite
Thamri A, Baccar H, Struzzi C, et al. MHDA-Functionalized Multiwall Carbon Nanotubes for detecting non-aromatic VOCs. Sci Rep. 2016;6:35130doi: 10.1038/srep35130.
Thamri, A., Baccar, H., Struzzi, C., Bittencourt, C., Abdelghani, A., & Llobet, E. (2016). MHDA-Functionalized Multiwall Carbon Nanotubes for detecting non-aromatic VOCs. Scientific reports, 635130. https://doi.org/10.1038/srep35130
Thamri, Atef, et al. "MHDA-Functionalized Multiwall Carbon Nanotubes for detecting non-aromatic VOCs." Scientific reports vol. 6 (2016): 35130. doi: https://doi.org/10.1038/srep35130
Thamri A, Baccar H, Struzzi C, Bittencourt C, Abdelghani A, Llobet E. MHDA-Functionalized Multiwall Carbon Nanotubes for detecting non-aromatic VOCs. Sci Rep. 2016 Oct 10;6:35130. doi: 10.1038/srep35130. PMID: 27721503; PMCID: PMC5056342.
Copy Download .nbib Format: NLM
Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes.

Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research

Abdelgany A, Ealing J, Wood M, Beeson D.
PMID: 19771201
J RNAi Gene Silencing. 2005 Jul 28;1(1):26-31.

Slow channel congenital myasthenic syndrome (SCCMS) is a dominant disorder caused by missense mutations in muscle acetylcholine receptors (AChR). Expression from mutant alleles causes prolonged AChR ion-channel activations. This 'gain of function' results in excitotoxic damage due to excess...

Cite
Abdelgany A, Ealing J, Wood M, et al. Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes. J RNAi Gene Silencing. 2005;1(1):26-31
Abdelgany, A., Ealing, J., Wood, M., & Beeson, D. (2005). Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes. Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research, 1(1), 26-31.
Abdelgany, Amr, et al. "Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes." Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research vol. 1,1 (2005): 26-31.
Abdelgany A, Ealing J, Wood M, Beeson D. Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes. J RNAi Gene Silencing. 2005 Jul 28;1(1):26-31. PMID: 19771201; PMCID: PMC2737193.
Copy Download .nbib Format: NLM
Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV).

Forensic science international

Abiedalla YF, Abdel-Hay K, DeRuiter J, Clark CR.
PMID: 22995045
Forensic Sci Int. 2012 Nov 30;223(1):189-97. doi: 10.1016/j.forsciint.2012.08.040. Epub 2012 Sep 17.

A series of ten homologous and regioisomeric aminoketones related to the designer synthetic cathinone derivative MDPV were evaluated in this study. These compounds were prepared from a common precursor chemical, piperonal (3,4-methylenedioxybenzaldehyde). These aminoketones show major peaks in their...

Cite
Abiedalla YF, Abdel-Hay K, DeRuiter J, et al. Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV). Forensic Sci Int. 2012;223(1):189-97doi: 10.1016/j.forsciint.2012.08.040.
Abiedalla, Y. F., Abdel-Hay, K., DeRuiter, J., & Clark, C. R. (2012). Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV). Forensic science international, 223(1), 189-97. https://doi.org/10.1016/j.forsciint.2012.08.040
Abiedalla, Younis F Hamad, et al. "Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV)." Forensic science international vol. 223,1 (2012): 189-97. doi: https://doi.org/10.1016/j.forsciint.2012.08.040
Abiedalla YF, Abdel-Hay K, DeRuiter J, Clark CR. Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV). Forensic Sci Int. 2012 Nov 30;223(1):189-97. doi: 10.1016/j.forsciint.2012.08.040. Epub 2012 Sep 17. PMID: 22995045.
Copy Download .nbib Format: NLM
Knowledge of Neonatal Hyperbilirubinemia Among Primary Health Care Physicians: A Single-Center Experience.

Clinical medicine insights. Pediatrics

Mostafa MA, Kamal NM, Eltaher S, Hamed Y, Abdelaziz H, Abdelghany W, Aser E, Fawzy E, Sherief LM.
PMID: 30853790
Clin Med Insights Pediatr. 2019 Mar 03;13:1179556518824375. doi: 10.1177/1179556518824375. eCollection 2019.

BACKGROUND AND OBJECTIVES: To evaluate the knowledge of the primary health care physicians (PHCP) in Kalubia governorate, Egypt, about the causes, diagnosis, complications, and treatment of neonatal hyperbilirubinemia (NHB).METHODS: Cross-sectional survey distributed by interview to 500 physicians working in...

Cite
Mostafa MA, Kamal NM, Eltaher S, et al. Knowledge of Neonatal Hyperbilirubinemia Among Primary Health Care Physicians: A Single-Center Experience. Clin Med Insights Pediatr. 2019;13:1179556518824375doi: 10.1177/1179556518824375.
Mostafa, M. A., Kamal, N. M., Eltaher, S., Hamed, Y., Abdelaziz, H., Abdelghany, W., Aser, E., Fawzy, E., & Sherief, L. M. (2019). Knowledge of Neonatal Hyperbilirubinemia Among Primary Health Care Physicians: A Single-Center Experience. Clinical medicine insights. Pediatrics, 131179556518824375. https://doi.org/10.1177/1179556518824375
Mostafa, Mostafa A, et al. "Knowledge of Neonatal Hyperbilirubinemia Among Primary Health Care Physicians: A Single-Center Experience." Clinical medicine insights. Pediatrics vol. 13 (2019): 1179556518824375. doi: https://doi.org/10.1177/1179556518824375
Mostafa MA, Kamal NM, Eltaher S, Hamed Y, Abdelaziz H, Abdelghany W, Aser E, Fawzy E, Sherief LM. Knowledge of Neonatal Hyperbilirubinemia Among Primary Health Care Physicians: A Single-Center Experience. Clin Med Insights Pediatr. 2019 Mar 03;13:1179556518824375. doi: 10.1177/1179556518824375. eCollection 2019. PMID: 30853790; PMCID: PMC6399760.
Copy Download .nbib Format: NLM
Photodegradation of methylene blue with PVA/PVP blend under UV light irradiation.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Zidan HM, El-Ghamaz NA, Abdelghany AM, Waly AL.
PMID: 29621699
Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jun 15;199:220-227. doi: 10.1016/j.saa.2018.03.057. Epub 2018 Mar 24.

Homogenous films of PVA/PVP blend (1:1) doped with different levels of methylene blue dye (MB) were prepared using the casting technique. The absorption spectra of doped PVA/PVP blend showed two absorption peaks due to the chromophor groups of MB...

Cite
Zidan HM, El-Ghamaz NA, Abdelghany AM, et al. Photodegradation of methylene blue with PVA/PVP blend under UV light irradiation. Spectrochim Acta A Mol Biomol Spectrosc. 2018;199:220-227doi: 10.1016/j.saa.2018.03.057.
Zidan, H. M., El-Ghamaz, N. A., Abdelghany, A. M., & Waly, A. L. (2018). Photodegradation of methylene blue with PVA/PVP blend under UV light irradiation. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 199220-227. https://doi.org/10.1016/j.saa.2018.03.057
Zidan, H M, et al. "Photodegradation of methylene blue with PVA/PVP blend under UV light irradiation." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 199 (2018): 220-227. doi: https://doi.org/10.1016/j.saa.2018.03.057
Zidan HM, El-Ghamaz NA, Abdelghany AM, Waly AL. Photodegradation of methylene blue with PVA/PVP blend under UV light irradiation. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jun 15;199:220-227. doi: 10.1016/j.saa.2018.03.057. Epub 2018 Mar 24. PMID: 29621699.
Copy Download .nbib Format: NLM
Letter by Abdelghany Regarding Article, "A Lead to the Culprit".

Circulation

Abdelghany M.
PMID: 29555720
Circulation. 2018 Mar 20;137(12):1305-1306. doi: 10.1161/CIRCULATIONAHA.117.031493.

No abstract available.

Cite
Abdelghany M. Letter by Abdelghany Regarding Article, "A Lead to the Culprit". Circulation. 2018;137(12):1305-1306doi: 10.1161/CIRCULATIONAHA.117.031493.
Abdelghany, M. (2018). Letter by Abdelghany Regarding Article, "A Lead to the Culprit". Circulation, 137(12), 1305-1306. https://doi.org/10.1161/CIRCULATIONAHA.117.031493
Abdelghany, Mahmoud. "Letter by Abdelghany Regarding Article, "A Lead to the Culprit"." Circulation vol. 137,12 (2018): 1305-1306. doi: https://doi.org/10.1161/CIRCULATIONAHA.117.031493
Abdelghany M. Letter by Abdelghany Regarding Article, "A Lead to the Culprit". Circulation. 2018 Mar 20;137(12):1305-1306. doi: 10.1161/CIRCULATIONAHA.117.031493. PMID: 29555720.
Copy Download .nbib Format: NLM
A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis.

Journal of computer-aided molecular design

Ben Khalaf N, Pham S, Romeo G, Abdelghany S, Intagliata S, Sedillo P, Salerno L, Gonzales J, Fathallah DM, Perkins DJ, Hurwitz I, Pittalà V.
PMID: 33615401
J Comput Aided Mol Des. 2021 Mar;35(3):297-314. doi: 10.1007/s10822-021-00374-w. Epub 2021 Feb 22.

Leishmaniasis is an infectious disease caused by parasites of the genus Leishmania and transmitted by the bite of a sand fly. To date, most available drugs for treatment are toxic and beyond the economic means of those affected by...

Cite
Ben Khalaf N, Pham S, Romeo G, et al. A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis. J Comput Aided Mol Des. 2021;35(3):297-314doi: 10.1007/s10822-021-00374-w.
Ben Khalaf, N., Pham, S., Romeo, G., Abdelghany, S., Intagliata, S., Sedillo, P., Salerno, L., Gonzales, J., Fathallah, D. M., Perkins, D. J., Hurwitz, I., & Pittalà, V. (2021). A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis. Journal of computer-aided molecular design, 35(3), 297-314. https://doi.org/10.1007/s10822-021-00374-w
Ben Khalaf, Noureddine, et al. "A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis." Journal of computer-aided molecular design vol. 35,3 (2021): 297-314. doi: https://doi.org/10.1007/s10822-021-00374-w
Ben Khalaf N, Pham S, Romeo G, Abdelghany S, Intagliata S, Sedillo P, Salerno L, Gonzales J, Fathallah DM, Perkins DJ, Hurwitz I, Pittalà V. A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis. J Comput Aided Mol Des. 2021 Mar;35(3):297-314. doi: 10.1007/s10822-021-00374-w. Epub 2021 Feb 22. PMID: 33615401.
Copy Download .nbib Format: NLM
Isolated Bulbar Palsy: A Rare Presentation of Neurosarcoidosis.

Cureus

Chaudhry HS, Ata F, Abdelghani M, Kazman R, Rahil A.
PMID: 32206474
Cureus. 2020 Feb 16;12(2):e7010. doi: 10.7759/cureus.7010.

Sarcoidosis, which is a non-caseating granulomatous chronic inflammatory disease, can affect virtually any organ system, including the central nervous system (CNS). Very rarely, patients may present solely with neurosarcoidosis. It commonly presents with unilateral or bilateral seventh nerve palsy....

Cite
Chaudhry HS, Ata F, Abdelghani M, et al. Isolated Bulbar Palsy: A Rare Presentation of Neurosarcoidosis. Cureus. 2020;12(2):e7010doi: 10.7759/cureus.7010.
Chaudhry, H. S., Ata, F., Abdelghani, M., Kazman, R., & Rahil, A. (2020). Isolated Bulbar Palsy: A Rare Presentation of Neurosarcoidosis. Cureus, 12(2), e7010. https://doi.org/10.7759/cureus.7010
Chaudhry, Hammad S, et al. "Isolated Bulbar Palsy: A Rare Presentation of Neurosarcoidosis." Cureus vol. 12,2 (2020): e7010. doi: https://doi.org/10.7759/cureus.7010
Chaudhry HS, Ata F, Abdelghani M, Kazman R, Rahil A. Isolated Bulbar Palsy: A Rare Presentation of Neurosarcoidosis. Cureus. 2020 Feb 16;12(2):e7010. doi: 10.7759/cureus.7010. PMID: 32206474; PMCID: PMC7077743.
Copy Download .nbib Format: NLM
Effect of maternal BMI on labor outcomes in primigravida pregnant women.

BMC pregnancy and childbirth

Khalifa E, El-Sateh A, Zeeneldin M, Abdelghany AM, Hosni M, Abdallah A, Salama S, Abdel-Rasheed M, Mohammad H.
PMID: 34749684
BMC Pregnancy Childbirth. 2021 Nov 08;21(1):753. doi: 10.1186/s12884-021-04236-z.

BACKGROUND: This study aims to detect the effects of increased BMI on labor outcomes in primigravida pregnant women.METHODS: A cross-sectional study involved 600 full-term singleton primigravida pregnant women who presented in the active phase of labor to the labor...

Cite
Khalifa E, El-Sateh A, Zeeneldin M, et al. Effect of maternal BMI on labor outcomes in primigravida pregnant women. BMC Pregnancy Childbirth. 2021;21(1):753doi: 10.1186/s12884-021-04236-z.
Khalifa, E., El-Sateh, A., Zeeneldin, M., Abdelghany, A. M., Hosni, M., Abdallah, A., Salama, S., Abdel-Rasheed, M., & Mohammad, H. (2021). Effect of maternal BMI on labor outcomes in primigravida pregnant women. BMC pregnancy and childbirth, 21(1), 753. https://doi.org/10.1186/s12884-021-04236-z
Khalifa, Eissa, et al. "Effect of maternal BMI on labor outcomes in primigravida pregnant women." BMC pregnancy and childbirth vol. 21,1 (2021): 753. doi: https://doi.org/10.1186/s12884-021-04236-z
Khalifa E, El-Sateh A, Zeeneldin M, Abdelghany AM, Hosni M, Abdallah A, Salama S, Abdel-Rasheed M, Mohammad H. Effect of maternal BMI on labor outcomes in primigravida pregnant women. BMC Pregnancy Childbirth. 2021 Nov 08;21(1):753. doi: 10.1186/s12884-021-04236-z. PMID: 34749684; PMCID: PMC8574020.
Copy Download .nbib Format: NLM
Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine.

Journal of biomedical materials research. Part A

AbdelAllah NH, Gaber Y, AbdelGhani S, Rashed ME, Azmy AF.
PMID: 34117696
J Biomed Mater Res A. 2021 Dec;109(12):2462-2470. doi: 10.1002/jbm.a.37240. Epub 2021 Jun 11.

Chitosan and alginate salts are natural biopolymers that have gained recent attention in the biomedical sectors. Their properties allow them to become potential candidates as safe, cheap, and effective vaccine adjuvants. The present study aimed to enhance the immunogenic...

Cite
AbdelAllah NH, Gaber Y, AbdelGhani S, et al. Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine. J Biomed Mater Res A. 2021;109(12):2462-2470doi: 10.1002/jbm.a.37240.
AbdelAllah, N. H., Gaber, Y., AbdelGhani, S., Rashed, M. E., & Azmy, A. F. (2021). Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine. Journal of biomedical materials research. Part A, 109(12), 2462-2470. https://doi.org/10.1002/jbm.a.37240
AbdelAllah, Nourhan H, et al. "Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine." Journal of biomedical materials research. Part A vol. 109,12 (2021): 2462-2470. doi: https://doi.org/10.1002/jbm.a.37240
AbdelAllah NH, Gaber Y, AbdelGhani S, Rashed ME, Azmy AF. Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine. J Biomed Mater Res A. 2021 Dec;109(12):2462-2470. doi: 10.1002/jbm.a.37240. Epub 2021 Jun 11. PMID: 34117696.
Copy Download .nbib Format: NLM
Movement disorders associated with neuronal antibodies: a data-driven approach.

Journal of neurology

Sturchio A, Dwivedi AK, Gastaldi M, Grimberg MB, Businaro P, Duque KR, Vizcarra JA, Abdelghany E, Balint B, Marsili L, Espay AJ.
PMID: 35024921
J Neurol. 2022 Jan 13; doi: 10.1007/s00415-021-10934-7. Epub 2022 Jan 13.

BACKGROUND: Movement disorders can be associated with anti-neuronal antibodies.METHODS: We conducted a systematic review of cases with documented anti-neuronal antibodies in serum and/or cerebrospinal fluid published in PubMed before April 1, 2020. Only patients with at least one movement...

Cite
Sturchio A, Dwivedi AK, Gastaldi M, et al. Movement disorders associated with neuronal antibodies: a data-driven approach. J Neurol. 2022;doi: 10.1007/s00415-021-10934-7.
Sturchio, A., Dwivedi, A. K., Gastaldi, M., Grimberg, M. B., Businaro, P., Duque, K. R., Vizcarra, J. A., Abdelghany, E., Balint, B., Marsili, L., & Espay, A. J. (2022). Movement disorders associated with neuronal antibodies: a data-driven approach. Journal of neurology, . https://doi.org/10.1007/s00415-021-10934-7
Sturchio, Andrea, et al. "Movement disorders associated with neuronal antibodies: a data-driven approach." Journal of neurology vol. (2022). doi: https://doi.org/10.1007/s00415-021-10934-7
Sturchio A, Dwivedi AK, Gastaldi M, Grimberg MB, Businaro P, Duque KR, Vizcarra JA, Abdelghany E, Balint B, Marsili L, Espay AJ. Movement disorders associated with neuronal antibodies: a data-driven approach. J Neurol. 2022 Jan 13; doi: 10.1007/s00415-021-10934-7. Epub 2022 Jan 13. PMID: 35024921.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 169 entries